A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/21114780

Download in:

View as

General Info

PMID
21114780